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Abstract
Adenylyl cyclase, E.C. 4.6.1.1, converts ATP to cyclic AMP and pyrophosphate. Mammalian membrane-
delimited adenylyl cyclases (nomenclature as approved by the NC-IUPHAR Subcommittee on Adenylyl
cyclases [10]) are typically made up of two clusters of six TM domains separating two intracellular, overlapping
catalytic domains that are the target for the nonselective activators Gαs (the stimulatory G protein α subunit)
and forskolin (except AC9, [26]). adenosine and its derivatives (e.g. 2',5'-dideoxyadenosine), acting through the
P-site,are inhibitors of adenylyl cyclase activity [33]. Four families of membranous adenylyl cyclase are
distinguishable: calmodulin-stimulated (AC1, AC3 and AC8), Ca2+- and Gβγ-inhibitable (AC5, AC6 and AC9),
Gβγ-stimulated and Ca2+-insensitive (AC2, AC4 and AC7), and forskolin-insensitive (AC9) forms. A soluble
adenylyl cyclase (AC10) lacks membrane spanning regions and is insensitive to G proteins.It functions as a
cytoplasmic bicarbonate (pH-insensitive) sensor [6].
Contents
This is a citation summary for Adenylyl cyclases (ACs) in the Guide to Pharmacology database (GtoPdb). It
exists purely as an adjunct to the database to facilitate the recognition of citations to and from the database by
citation analyzers. Readers will almost certainly want to visit the relevant sections of the database which are
given here under database links.
GtoPdb is an expert-driven guide to pharmacological targets and the substances that act on them. GtoPdb is a
reference work which is most usefully represented as an on-line database. As in any publication this work
should be appropriately cited, and the papers it cites should also be recognized. This document provides a
citation for the relevant parts of the database, and also provides a reference list for the research cited by those
parts.
Please note that the database version for the citations given in GtoPdb are to the most recent preceding version
in which the family or its subfamilies and targets were substantially changed. The links below are to the current
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            AC1(adenylyl cyclase 1)
            http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1278
            AC2(adenylyl cyclase 2)
            http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1279
            AC3(adenylyl cyclase 3)
            http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1280
            AC4(adenylyl cyclase 4)
            http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1281
            AC5(adenylyl cyclase 5)
            http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1282
            AC6(adenylyl cyclase 6)
            http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1283
            AC7(adenylyl cyclase 7)
            http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1284
            AC8(adenylyl cyclase 8)
            http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1285
            AC9(adenylyl cyclase 9)
            http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1286
            AC10(adenylyl cyclase 10)
            http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3068
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